WHO chief scientist welcomes India’s decision to restart COVID-19 vaccine exports

New Delhi: Chief scientist of World Health Organization (WHO) Dr Soumya Swaminathan on Tuesday welcomed India’s decision to restart COVID-19 vaccine exports. She said that the decision will go long way to achieve global Vaccine Equity.

“COVAX welcomes the decision to restart Covid vaccine exports. Will go a long way to achieve global Vaccine Equity,” Soumya Swaminathan said in a tweet.

Union Minister of Health and Family Welfare Mansukh Mandaviya on Monday announced that in the fourth quarter this year, the Government of India will resume Vaccine Maitri, an initiative to provide Covid vaccines to countries around the world and also fulfil its responsibility under Covax.

“Under Vaccine Maitri, we will help the world and contribute to Covax in the fourth quarter,” Mandaviya said to reporters. He also announced that next month government is expecting more than 30 crore doses from vaccine manufacturers.

Health Minister estimated the target of the fourth quarter this year to be around 100 crores and highlighted that vaccination of own citizens is the topmost priority.

Meanwhile, with the administration of 96,46,778 vaccine doses in the last 24 hours, India’s COVID-19 vaccination coverage exceeded 81.85 crores (81,85,13,827) as per provisional reports till 7 am on Tuesday, informed the Ministry of Health and Family Welfare.

The ministry said that this has been achieved through 80,35,135 sessions.

As per the data, as many as 1,03,69,386 healthcare workers have been inoculated with the first dose of COVID vaccine while 87,50,107 have been inoculated with both doses. The number of frontline workers vaccinated stands at 1,83,46,016 (first dose) and 1,45,66,593 (two doses).

Early this year, India halted vaccine exports as coronavirus cases surged in the country.

  • Related Posts

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    India’s $30-billion pharma industry is staring at a fresh challenge after US President Donald Trump announced that generic medicines imported into the US would face tariffs of 100% from Aug…

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    New Delhi: A joint operation by the Delhi Police Crime Branch, the Central Drugs Standard Control Organisation (CDSCO) and the Gautam Buddha Nagar District Drug Department uncovered a suspected illegal…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

    Fake Medicines Worth Over Rs 5 Crore Seized From Factory In Uttarakhand’s Dehradun

    Fake Medicines Worth Over Rs 5 Crore Seized From Factory In Uttarakhand’s Dehradun

    A ‘Fatal Flaw’ might be lurking in apparently Healthy Heart- Dr Devi Shetty

    A ‘Fatal Flaw’ might be lurking in apparently Healthy Heart- Dr Devi Shetty

    CDSCO declares 159 drug samples as NSQs in June

    CDSCO declares 159 drug samples as NSQs in June